The VESPA Pilot Study

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age45-80
SponsorWake Forest University

About this trial

Physical activity has been described by the US federal government as a 'best buy' for public health. Unfortunately, most adults in the United States are not sufficiently active, and this worsens with age. Low levels of participation are driven by many challenging barriers, including lack of access, few opportunities for enjoyable activity, and few supportive social relationships, which is especially important given the central role of social connection for lasting behavior change.

A half-century of research in behavioral sciences has generated effective group-based physical activity programs, but these are inaccessible to most as they are often delivered in a few select research centers. Recent advances in telehealth have offered media for extending these interventions more broadly, but the experience of such programs is often hampered by technology that does not allow for a sense of physical and social presence. Fortunately, uptake of virtual reality (VR) is increasing rapidly, and the medium has a high level of potential for advancing the delivery of immersive evidence-based group interventions to those that most need it. Thus our specific aims are:

Specific aim 1: To test the feasibility and acceptability of a group-mediated physical activity intervention delivered fully via modern VR to older adults.

Specific aim 2: To examine the impact of this program on overall physical activity among older adults compared to the current standard-of-care for telehealth: the video conference meeting platform.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Age of 45-80 years

Body mass index between 30-45 kg/m2

Low-active (30 or more minutes of moderate intensity physical activity on 2 or fewer days per week)

Have access to home Wi-Fi

Disqualifiers

Current involvement in other physical activity research studies

Hearing or sight impairments (significant visual or hearing impairment that cannot be corrected and results in the inability to use the telephone or hear normal conversation, colorblindness)

Dependence on a cane or walker

More than 1 fall in the past year

Trial design

Design model

Parallel

Treatments tested in this trial

  • Virtual Reality

    Behavioral

    Participants in this arm participate in 4 group-based behavioral counseling sessions plus 8 one-on-one coaching session within virtual reality software. Participants aim to engage in approximately 150 minutes per week of moderate-to-vigorous activity, with options including both virtual reality and real-world physical activities.

  • Video Conference

    Behavioral

    Participants in this arm participate in 4 group-based behavioral counseling sessions plus 8 one-on-one coaching session within video conference software. Participants aim to engage in approximately 150 minutes per week of moderate-to-vigorous activity, with options including both streaming video and real-world physical activities.

Treatment groups

30 Participants
are divided into 2 treatment groups
Group A: Virtual RealityExperimental treatment 1 intervention
Group B: Video ConferenceActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

The percentage of individuals attending all one-on-one and group calls

Feasibility will be assessed based on percentage of individuals attending all one-on-one and group calls

Time frame
Weeks 0 through 4
2

Acceptability

Percentage of individuals reporting no severe symptoms in response to virtual reality on the virtual reality sickness questionnaire

Time frame
Baseline

Secondary outcomes

1

Physical Activity

Average daily steps over one week as recorded via Garmin VivoSmart 4

Time frame
Baseline, Week 4
2

Social Relatedness

Score on the social relatedness subscale of the Brief Psychological Needs Satisfaction and Frustration Scale

Time frame
Baseline, Week 4

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Wake Forest University

Lead sponsor

Wells Fargo Faculty Scholar Endowment

Collaborator